Mind Medicine (MindMed) - 5 Year Stock Price History | MNMD

The latest closing stock price for Mind Medicine (MindMed) as of February 21, 2025 is 7.63.

  • An investor who bought $1,000 worth of Mind Medicine (MindMed) stock at the IPO in 2020 would have $9,173 today, roughly 9 times their original investment - a 59.03% compound annual growth rate over 5 years.
  • The all-time high Mind Medicine (MindMed) stock closing price was 68.55 on April 28, 2021.
  • The Mind Medicine (MindMed) 52-week high stock price is 12.22, which is 60.2% above the current share price.
  • The Mind Medicine (MindMed) 52-week low stock price is 4.66, which is 38.9% below the current share price.
  • The average Mind Medicine (MindMed) stock price for the last 52 weeks is 7.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

Mind Medicine (MindMed) - 5 Year Stock Price History | MNMD

  • An investor who bought $1,000 worth of Mind Medicine (MindMed) stock at the IPO in 2020 would have $9,173 today, roughly 9 times their original investment - a 59.03% compound annual growth rate over 5 years.
  • The all-time high Mind Medicine (MindMed) stock closing price was 68.55 on April 28, 2021.
  • The Mind Medicine (MindMed) 52-week high stock price is 12.22, which is 60.2% above the current share price.
  • The Mind Medicine (MindMed) 52-week low stock price is 4.66, which is 38.9% below the current share price.
  • The average Mind Medicine (MindMed) stock price for the last 52 weeks is 7.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$231.2B
Amgen (AMGN)$160B
Gilead Sciences (GILD)$137.1B
Vertex Pharmaceuticals (VRTX)$123.3B
Bristol Myers Squibb (BMY)$113.2B
CSL (CSLLY)$80.1B
GSK (GSK)$76.6B
Regeneron Pharmaceuticals (REGN)$76.1B
Argenex SE (ARGX)$39.3B
Alnylam Pharmaceuticals (ALNY)$32.5B
BioNTech SE (BNTX)$28.3B
BeiGene (ONC)$23.9B
Biogen (BIIB)$20.1B
Illumina (ILMN)$15.4B
Insmed (INSM)$15B
Genmab (GMAB)$14.9B
Genmab (GNMSF)$14.7B
Incyte (INCY)$13.8B
Intra-Cellular Therapies (ITCI)$13.7B
BioMarin Pharmaceutical (BMRN)$13.1B
Moderna (MRNA)$13B
Swedish Orphan Biovitrum (BIOVF)$10.9B
Sarepta Therapeutics (SRPT)$10.4B
Bio-Techne Corp (TECH)$10.4B
Vaxcyte (PCVX)$10.3B
Exelixis (EXEL)$9.8B
Ascendis Pharma (ASND)$9.4B
Exact Sciences (EXAS)$9.2B
Repligen (RGEN)$9.1B
Bio-Rad Laboratories (BIO.B)$8.7B